Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region

被引:0
|
作者
Kumar, P. [1 ]
Vuyyuru, S. K. [1 ]
Kante, B. [1 ]
Sahu, P. [1 ]
Goyal, S. [1 ]
Madhu, D. [1 ]
Jain, S. [1 ]
Ranjan, M. K. [1 ]
Mundhra, S. [1 ]
Golla, R. [1 ]
Singh, M. [1 ]
Virmani, S. [1 ]
Gupta, A. [1 ]
Yadav, N. [1 ]
Kalaivani, M. [1 ]
Sharma, R. [1 ]
Das, P. [1 ]
Makharia, G. [1 ]
Kedia, S. [1 ]
Ahuja, V. [1 ]
机构
[1] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P531
引用
收藏
页码:I484 / I484
页数:1
相关论文
共 50 条
  • [31] Withdrawal of anti-TNF therapy and use of combination therapy in inflammatory bowel disease varies significantly in Australia
    Gupta, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 135 - 135
  • [32] The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy
    Mantzaris, Gerassimos J.
    Tsironikos, Dimitrios
    Tzanetakou, Xanthipi
    Grispou, Eirini
    Karatzas, Pantelis
    Kalogeropoulos, Ioannis
    Papamichael, Konstantinos
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (12) : 1451 - 1455
  • [33] Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
    Desai, Amit
    Zator, Zachary A.
    de Silva, Punyanganie
    Nguyen, Deanna D.
    Korzenik, Joshua
    Yajnik, Vijay
    Ananthakrishnan, Ashwin N.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 309 - 315
  • [34] The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease
    Paschou, Stavroula A.
    Palioura, Eleni
    Kothonas, Fotios
    Myroforidis, Alexandros
    Loi, Vasiliki
    Poulou, Androniki
    Goumas, Konstantinos
    Effraimidis, Grigoris
    Vryonidou, Andromachi
    ENDOCRINE JOURNAL, 2018, 65 (11) : 1121 - 1125
  • [35] Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease
    Ortega, Triana Lobaton
    Vermeire, Severine
    Ballet, Vera
    Rutgeerts, Paul J.
    Van Assche, Gert A.
    Ferrante, Marc
    GASTROENTEROLOGY, 2014, 146 (05) : S579 - S579
  • [36] Effect of Anti-TNFα Therapy on Prevalence of Depression in Patients With Inflammatory Bowel Disease
    Loomes, Dustin E.
    Dittrich, Alexandra E.
    Madsen, Karen
    Dieleman, Levinus A.
    Halloran, Brendan P.
    Fedorak, Richard N.
    Kroeker, Karen I.
    GASTROENTEROLOGY, 2014, 146 (05) : S779 - S779
  • [37] Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
    Lobaton, T.
    Ferrante, M.
    Rutgeerts, P.
    Ballet, V.
    Van Assche, G.
    Vermeire, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 441 - 451
  • [38] Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
    D'Ovidio, Valeria
    Vernia, Piero
    Gentile, Giuseppe
    Capobianchi, Angela
    Marcheggiano, Adriana
    Viscido, Angelo
    Martino, Pietro
    Caprilli, Renzo
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (02) : 180 - 183
  • [39] PROFILE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO DEVELOPED ACTIVE TUBERCULOSIS DESPITE NEGATIVE SCREENING PRIOR TO THE INTRODUCTION OF ANTI-TNF THERAPY
    Barros, Luciana
    Braga, Claudia
    Gomes, Tarcia N.
    Ambrogini Junior, Orlando
    GASTROENTEROLOGY, 2019, 156 (06) : S636 - S636
  • [40] Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease
    Castro, Beatriz
    Rivero, Montserrat
    Crespo, Javier
    Antonio Riancho, J.
    Valero, Carmen
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 39 : E33 - E34